Cover Image
Market Research Report

Europe Polymerase Chain Reaction Market Forecast 2019-2027

Published by Inkwood Research Product code 837252
Published Content info 80 Pages
Delivery time: 2-3 business days
Price
Back to Top
Europe Polymerase Chain Reaction Market Forecast 2019-2027
Published: May 13, 2019 Content info: 80 Pages
Description

KEY FINDINGS

The Europe polymerase chain reaction market generated a revenue of $XX million in 2018 and is projected to reach $XX million by 2027, at a CAGR of 6.21% through 2019-2027. The rising number of end users in proteomics and genomics market is boosting the growth of the conventional PCR machines in the Europe market.

MARKET INSIGHTS

The countries of France, Spain, Italy, United Kingdom, Germany and the remaining countries formulating the Rest of Europe regional segment are considered for the market study. Increasing competition coupled with price burden will outlay the PCR market. The rising awareness among end-users regarding usage of the PCR. However, the high costs associated with the required reagents and consumables is a major concern which will be hampering the growth of the market in the Europe region.

The German market for PCR is driven by the increasing demand of PCR tests for detection of infectious diseases like tuberculosis which is rampant in the country. The rising aging population is the key factor for the market expansion in Germany.

COMPETITIVE INSIGHTS

The major companies operating in the market are Pacific Biosciences of California, Inc., Qiagen N.V., F. Hoffman La Roche Ltd., Becton Dickinson Biosciences Systems and Reagents Inc., Siemens Healthineers, Fluidigm Corporation, MDXhealth Corporation, Nano Biosys Inc., Biomerieux SA, Bio-Rad Technologies Inc., Danaher Corporation, Tahara Bio Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., and Abbott Laboratories, which have been thoroughly summed up in the report.

Table of Contents
Product Code: 24954

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. REAGENTS AND CONSUMABLES HOLDS THE LARGEST MARKET SHARE
    • 3.2.2. RISE IN INFECTIOUS DISEASES WORLDWIDE
    • 3.2.3. INCREASING DEMAND FOR DIGITAL PCR

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISING INCIDENCES OF INFECTIONS AND DISEASES
    • 4.2.2. DEVELOPMENT IN PHARMACOGENOMICS
    • 4.2.3. EMERGENCE OF DIGITAL PCR
    • 4.2.4. INCREASING PUBLIC-PRIVATE INVESTMENTS AND GRANTS
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. NON-VALIDATED HOME BREW TESTS
    • 4.3.2. HIGH DEVICE COSTS ASSOCIATED WITH PCR
    • 4.3.3. NECESSITY OF TRAINING AND UPDATION OF LABORATORIES WORKERS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. RISE IN FUNDING OF GENE AND HUMAN GENOME PROJECTS
    • 4.4.2. EXPANDING HEALTHCARE MARKET IN APAC
  • 4.5. MARKET CHALLENGES
    • 4.5.1. INACCURACY CAUSED BY THE PCR TECHNIQUES
    • 4.5.2. INCREASING AVAILABILITY OF ALTERNATIVE TECHNOLOGIES

5. MARKET BY TECHNOLOGY

  • 5.1. REAL-TIME PCR
  • 5.2. TRADITIONAL PCR
  • 5.3. DIGITAL PCR

6. MARKET BY PRODUCT

  • 6.1. REAGENT AND CONSUMABLES
  • 6.2. INSTRUMENTS
  • 6.3. SOFTWARE
  • 6.4. SERVICES

7. MARKET BY APPLICATION

  • 7.1. CLINICAL
  • 7.2. RESEARCH
  • 7.3. FORENSICS

8. MARKET BY END-USER

  • 8.1. DIAGNOSTIC CENTERS & HOSPITALS
  • 8.2. BIOTECH & PHARMA COMPANIES
  • 8.3. ACADEMIC AND RESEARCH INSTITUTES

9. KEY ANALYTICS

  • 9.1. PORTER'S FIVE FORCE MODEL
    • 9.1.1. THREAT OF NEW ENTRANTS
    • 9.1.2. THREAT OF SUBSTITUTE
    • 9.1.3. BARGAINING POWER OF SUPPLIERS
    • 9.1.4. BARGAINING POWER OF BUYERS
    • 9.1.5. THREAT OF COMPETITIVE RIVALRY
  • 9.2. OPPORTUNITY MATRIX
  • 9.3. VENDOR LANDSCAPE

10. GEOGRAPHICAL ANALYSIS- EUROPE

    • 10.1.1. UNITED KINGDOM
    • 10.1.2. GERMANY
    • 10.1.3. FRANCE
    • 10.1.4. SPAIN
    • 10.1.5. ITALY
    • 10.1.6. REST OF EUROPE

11. COMPETITIVE LANDSCAPE

  • 11.1. COMPANY PROFILES
    • 11.1.1. AGILENT TECHNOLOGIES INC.
    • 11.1.2. BIORAD TECHNOLOGIES INC.
    • 11.1.3. QIAGEN N.V.
    • 11.1.4. F. HOFFMAN LA ROCHE LTD.
    • 11.1.5. THERMOFISHER SCIENTIFIC INC.
    • 11.1.6. ABBOTT LABORATORIES
    • 11.1.7. BECTON DICKINSON BIOSCIENCES SYSTEMS AND REAGENTS INC.
    • 11.1.8. SIEMENS HEALTHINEERS
    • 11.1.9. BIOMERIEUX SA
    • 11.1.10. DANAHER CORPORATION
    • 11.1.11. MDXHEALTH CORPORATION
    • 11.1.12. NANO BIOSYS INC.
    • 11.1.13. TAHARA BIO INC.
    • 11.1.14. FLUIDIGM CORPORATION
    • 11.1.15. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

LIST OF TABLES

  • TABLE 1. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)
  • TABLE 2. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TECHNOLOGY, 2019-2027, (IN $ MILLION)
  • TABLE 3. GLOBAL PCR MARKET, BY REAL-TIME PCR, 2019-2027 (IN $ MILLION)
  • TABLE 4. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT, 2019-2027, (IN $ MILLION)
  • TABLE 5. GLOBAL REAGENT AND CONSUMABLES MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 6. GLOBAL INSTRUMENTS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 7. GLOBAL SOFTWARE MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 8. GLOBAL SERVICES MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 9. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2019-2027, (IN $ MILLION)
  • TABLE 10. GLOBAL CLINICAL MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 11. GLOBAL RESEARCH MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 12. GLOBAL FORENSICS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 13. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END-USER 2019-2027 (IN $ MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC CENTERS & HOSPITALS MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 15. GLOBAL BIOTECH AND PHARMA COMPANIES MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 16. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET, BY REGION, 2019-2027 (IN $ MILLION)
  • TABLE 17. OPPORTUNITY MATRIX
  • TABLE 18. VENDOR LANDSCAPE
  • TABLE 19. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)
  • TABLE 20. EUROPE POLYMERASE CHAIN REACTION (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2018 & 2027 (IN %)
  • FIGURE 2. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY REAL-TIME PCR, 2019-2027 (IN $ MILLION)
  • FIGURE 3. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TRADITIONAL PCR, 2019-2027 (IN $ MILLION)
  • FIGURE 4. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 (IN $ MILLION)
  • FIGURE 5. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY INSTRUMENTS, 2019-2027 (IN $ MILLION)
  • FIGURE 6. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY SOFTWARE, 2019-2027 (IN $ MILLION)
  • FIGURE 7. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY SERVICES, 2019-2027 (IN $ MILLION)
  • FIGURE 8. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY CLINICAL, 2019-2027 (IN $ MILLION)
  • FIGURE 9. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY RESEARCH, 2019-2027 (IN $ MILLION)
  • FIGURE 10. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY FORENSICS, 2019-2027 (IN $ MILLION)
  • FIGURE 11. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY DIAGNOSTIC CENTERS & HOSPITALS, 2019-2027 (IN $ MILLION)
  • FIGURE 12. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY BIOTECH & PHARMA COMPANIES, 2019-2027 (IN $ MILLION)
  • FIGURE 13. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2019-2027 (IN $ MILLION)
  • FIGURE 14. PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 15. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
  • FIGURE 16. UNITED KINGDOM POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 17. GERMANY POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 18. FRANCE POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 19. SPAIN POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 20. ITALY POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)
  • FIGURE 21. REST OF EUROPE POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)
Back to Top